With the spate of recent issues resulting in money getting locked up and funded bets made on the last two offerings resulting in losses, fi...

Larger issues like Devyani International is commanding a premium of 70-75 per cent, or Rs 63-65, over its price band of Rs 86-90, whereas K...

Analysts say that a poor sentiment in the pharma sector could be weighing on Glenmark Life Sciences' premium in the grey market.

The Rs 1,514 crore-initial public offering of Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, was subscribed more than 45...

Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...

Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...

Analysts are positive on the company's prospects, given that China Plus One strategy by global formulation makers -- to de-risk their procu...

With a portfolio of 120 molecules, GLS is a leading developer of select high-value, non-commoditised APIs in chronic therapies. It earns on...

Considering the FY-21 adjusted EPS of Rs 28.69 on post issue basis, the upper price band of Glenmark Life Sciences IPO implies a P/E of 25....

The company has decided to allocate 63,06,660 equity shares to 19 anchor investors at Rs 720 a share, aggregating to Rs 454 crore, accordin...

Glenmark’s share sale will be the 27th IPO of the year and fifth offering in July after GR Infraprojects, Clean Science and Technology, Zom...

At the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...

The initial public offering (IPO) comprises a fresh issue of Rs 1,160 crore and sale of 7.3 million shares by listed promoter Glenmark Phar...

The parent company of Naukri.com owns about 18.5% of Zomato and will sell shares worth $100 million in the IPO.

The initial public offer (IPO) of Utkarsh Small Finance Bank comprises fresh issue of equity shares worth Rs 750 crore and an offer for sal...

At least 12 drug makers and healthcare companies are planning IPOs in 2021 as the pandemic increases investor demand for the promising play...

The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Lif...